Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC403

Daridorexant eða lyfjafræðilega viðunandi salt þar af, sérstaklega daridorexant hýdróklóríð

  • Status:
    Veitt
  • Application date:
    21.9.2022
  • Application published:
    15.10.2022
  • Grant published:
    15.1.2025
  • Max expiry date:
    1.5.2037
  • Medicine name:
    Quviviq
  • Medicine for children:
    No

Timeline

Today
21.9.2022Application
15.10.2022Publication
15.1.2025Registration
1.5.2037Expires

Marketing license

  • IS authorization number:
    EU/1/22/1638/001-002; EU/1/22/1638/003-004
  • Date:
    28.6.2022
  • Foreign authorization number:
    EU/1/22/1638
  • Date:
    29.4.2022

Owner

  • Name:
    Idorsia Pharmaceuticals Ltd
  • Address:
    Hegenheimermattweg 91, CH-4123 Allschwil CH

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 11.01.2025

Upload documents